Skip to main content
OpenTrials
Completed

NCT Number: NCT05045547

Village Malaria Worker Expansion

This project will conduct pragmatic operational research in rural communities served by approximately 12 health centres and 120 village malaria workers in Battambang/Pailin, western Cambodia.

This study is funded by Global Fund/Regional Artemisinin Initiative (RAI3E). The grant reference number is QSE-M-UNOPS-MORU-20864-007-42

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sex eligibility

All sexes

Study type

Observational

Primary location

Action for Health and Development

Battambang, Cambodia

About this study

This is an integration of activities with the South and Southeast Asian Community-based Trials Network (SEACTN) that is ongoing in Lao PDR and Bangladesh. The SEACTN study aims to identify the most relevant ways in which village health worker roles can be expanded to include management of community febrile illness. A number of SEACTN activities will also be conducted in Cambodia alongside this project.

For this project, the study team will test specific examples of expanded roles of VMWs including testing for other causes of fever in people who are malaria negative and assessing the feasibility of diagnostics other than malaria RDTs at health centres. Quantitative and qualitative data will be collected to determine acceptability, a mixed-methods approach will be used for the assessment:

  • Quantitative method

Participants with febrile illness attending village malaria workers will be tested by novel rapid diagnostic tests (Dengue and CRP rapid test) in addition to a standard malaria test. Village malaria workers (VMWs)/ mobile malaria workers (MMWs) will be trained to conduct a package of activities ((i) hygiene and sanitation; (ii) disease surveillance; (iii) EPI and ANC support; (iv) management of mild common illnesses that they will carry out alongside their usual role of testing (RDTs) and treating malaria. If possible, within a week of conducting a novel RDT, a well-being follow up will be undertaken by the VMW, either via telephone or face-to-face. For the primary outcomes, the study team will report numbers and proportions of training modules passed, malaria tests performed, new diagnostic tests performed correctly, algorithms followed correctly, number of consultations, coverage estimates, and the study team will use the national malaria information system to provide a comparison in activity levels compared to other areas of Cambodia. The study team will record the incidence and aetiology of febrile illnesses.

  • Qualitative method

A set of interviews/discussions with health centre staffs and local stakeholders will be conducted to refine the intervention design and implementation strategy. To this end, the interviews will elicit the views and experience of local stakeholders on (1) health care needs and gaps in local communities, (2) views and past experiences concerning the implementation of the VMW programme, with a focus on challenges and good practices around the use of RDTs, and (3) their views about suitable methods and strategies to expand the current VMW programme considering the new technologies available.

Findings from the study will highlight to the wider scientific community the benefits and challenges of expanding the roles of VMW/MMWs.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Quantitative research
  • Written informed consent
  • Willingness to provide blood sample
  • Fever (≥37.5 C) or history of fever within 24 hours
  • Qualitative research

2.1 Health centre-based evaluation of novel diagnostics

  • Health centre staff who have received training in the use of the novel diagnostics used in the study
  • Willing and able to give informed consent for participation in the study

2.2 Stakeholder analysis

  • Adults, male or female, aged 18 years and over
  • Willing and able to give informed consent for participation in the study

Exclusion criteria

  • Quantitative research
  • Participants requires urgent medical attention
  • Qualitative research
  • Identified with intellectual and/or cognitive disability
  • History of or current psychiatric illness

Treatment and study plan

Primary outcomes

  1. The number of VMW consultations by patients

    Time frame: Approximately 18-24 months

    The number of VMW consultations by patients with a febrile and/or non-febrile illness along with the number of malaria RDTs used will be recorded. Comparing these data across the different intervention packages introduced for VMWs.

Secondary outcomes

  1. The number of VMWs that can correctly perform RDTS following a directly observed practical assessment and questionnaire.

    Time frame: Approximately 18-24 months

    The number of VMWs that can correctly perform RDTS following a directly observed practical assessment and questionnaire.

  2. The number of VMWs who correctly follow the treatment algorithms following a directly observed practical assessment and questionnaire.

    Time frame: Approximately 18-24 months

    The number of VMWs who correctly follow the treatment algorithms following a directly observed practical assessment and questionnaire.

  3. The overall consensus of stakeholders regarding the new roles of VMWs following stakeholder interviews

    Time frame: 0 months, mid-point of the study (12 months) and at study completion (24 months)

    The overall consensus of stakeholders regarding the new roles of VMWs following stakeholder interviews

  4. The overall consensus of stakeholders of the impact on non-malarial febrile illness management following stakeholder interviews

    Time frame: 0 months, mid-point of the study (12 months) and at study completion (24 months)

    The overall consensus of stakeholders of the impact on non-malarial febrile illness management following stakeholder interviews

  5. The number of VMWs that can correctly deliver one of four health intervention packages following a directly observed practical assessment and questionnaire.

    Time frame: 0 months, mid-point of the study (12 months) and at study completion (24 months)

    The number of VMWs that can correctly deliver one of four health intervention packages following a directly observed practical assessment and questionnaire.

  6. The number of health centre staff that can correctly perform RDTs following a directly observed practical assessment and questionnaire

    Time frame: Approximately 18-24 months

    The number of health centre staff that can correctly perform RDTs following a directly observed practical assessment and questionnaire

  7. The overall consensus of stakeholders on the use of novel RDTs following stakeholder interviews and focus group discussions.

    Time frame: Approximately 18-24 months

    The overall consensus of stakeholders on the use of novel RDTs following stakeholder interviews and focus group discussions.

  8. The overall consensus of stakeholders regarding these new roles following stakeholder interviews

    Time frame: At study completion (24 months)

    The overall consensus of stakeholders regarding these new roles following stakeholder interviews

Other outcomes

  1. The number of patients appropriately referred for further care

    Time frame: Approximately 18-24 months

    The number of patients appropriately referred for further care

Sponsors and collaborators

Lead sponsor

University of Oxford

Other

Collaborators

  • Mahidol Oxford Tropical Medicine Research Unit

Registry information

Official study title

Expanding the Roles of Village Malaria Workers: Operational Research in Cambodia

Acronym: CAM-VMW

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Sep 16, 2021
Registry last updated
Mar 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.